Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.
de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Rifai N, Tanasijevic M, Giugliano RP, Schuhwerk KC, McCabe CH, Cannon CP, Antman EM, Braunwald E; TIMI 14 Investigators. Thrombosis In Myocardial Infarction. de Lemos JA, et al. Among authors: braunwald e. Am J Cardiol. 2001 Aug 15;88(4):353-8. doi: 10.1016/s0002-9149(01)01678-2. Am J Cardiol. 2001. PMID: 11545753
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E. Anderson HV, et al. Among authors: braunwald e. J Am Coll Cardiol. 1995 Dec;26(7):1643-50. doi: 10.1016/0735-1097(95)00404-1. J Am Coll Cardiol. 1995. PMID: 7594098 Free article. Clinical Trial.
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Tanasijevic MJ, et al. Among authors: braunwald e. J Am Coll Cardiol. 1999 Sep;34(3):739-47. doi: 10.1016/s0735-1097(99)00274-0. J Am Coll Cardiol. 1999. PMID: 10483955 Free article. Clinical Trial.
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group.
Gibson CM, Murphy SA, Marble SJ, McCabe CH, Antman EM, Cannon CP, Braunwald E; Thrombolysis in Myocardial Infarction (TIMI) Study Group. Gibson CM, et al. Among authors: braunwald e. Am J Cardiol. 2001 Feb 15;87(4):450-3, A6. doi: 10.1016/s0002-9149(00)01402-8. Am J Cardiol. 2001. PMID: 11179533
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
de Lemos JA, Gibson CM, Antman EM, Murphy SA, Morrow DA, Schuhwerk KC, Schweiger M, Coussement P, Van de Werf F, Braunwald E; TIMI 14 Investigators. de Lemos JA, et al. Among authors: braunwald e. Am Heart J. 2001 Apr;141(4):592-8. doi: 10.1067/mhj.2001.113574. Am Heart J. 2001. PMID: 11275925
1,621 results